Explore Our Latest News

Stay Up to Date on the Breakthroughs and Events Shaping the Future of Radiopharmaceuticals

Upcoming Events

May 30 – June 2, 2026 | Los Angeles, CA

SNMMI Annual Meeting

Press Releases

March 12, 2024

Ratio Announces Expansion of Manufacturing Agreement with PharmaLogic for FAP-Targeted Radiopharmaceuticals

Read

March 4, 2024

Intermountain Health and PharmaLogic Partner to Develop and Expand Access to Novel Radiopharmaceuticals at New Salt Lake City Facility

Read

January 12, 2024

ARTBIO and PharmaLogic Announce Supply Agreement for Lead-212 based Therapeutic Candidate AB001 for New York and Surrounding States

Read

December 20, 2023

Meilleur Technologies Inc. Announces Execution of Manufacturing Agreement with PharmaLogic for Production of the Next-Generation Amyloid PET Imaging Biomarker, NAV4694

Read

October 10, 2023

Eckert & Ziegler and PharmaLogic Sign Reservation Agreement for Supply of Therapeutic Radioisotope Actinium-225

Read

July 11, 2023

Ratio Therapeutics, In Collaboration with Lantheus and PharmaLogic, Announce First Patient Dosed in Phase I Study Evaluating a Novel FAP-Targeted Radiopharmaceutical for PET Imaging

Read